Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna, Inc.

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Investments

Investments %Chg

Investments Common Size

Accounts Receivable, Net

Accounts Receivable, Net %Chg

Accounts Receivable, Net Common Size

Accounts Receivable from Related Party

Accounts Receivable from Related Party %Chg

Accounts Receivable from Related Party Common Size

Inventory

Inventory %Chg

Inventory Common Size

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets %Chg

Prepaid Expenses and Other Current Assets Common Size

Restricted Cash

Restricted Cash %Chg

Restricted Cash Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Investments, Non-Current

Investments, Non-Current %Chg

Investments, Non-Current Common Size

Property, Plant and Equipment, Net

Property, Plant and Equipment, Net %Chg

Property, Plant and Equipment, Net Common Size

Right-of-Use Assets, Operating Leases

Right-of-Use Assets, Operating Leases %Chg

Right-of-Use Assets, Operating Leases Common Size

Restricted Cash, Non-Current

Restricted Cash, Non-Current %Chg

Restricted Cash, Non-Current Common Size

Deferred Tax Assets

Deferred Tax Assets %Chg

Deferred Tax Assets Common Size

Other Non-Current Assets

Other Non-Current Assets %Chg

Other Non-Current Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Accrued Liabilities

Accrued Liabilities %Chg

Accrued Liabilities Common Size

Deferred Revenue

Deferred Revenue %Chg

Deferred Revenue Common Size

Income Taxes Payable

Income Taxes Payable %Chg

Income Taxes Payable Common Size

Other Current Liabilities

Other Current Liabilities %Chg

Other Current Liabilities Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Deferred Revenue, Non-Current

Deferred Revenue, Non-Current %Chg

Deferred Revenue, Non-Current Common Size

Operating Lease Liabilities, Non-Current

Operating Lease Liabilities, Non-Current %Chg

Operating Lease Liabilities, Non-Current Common Size

Financing Lease Liabilities, Non-Current

Financing Lease Liabilities, Non-Current %Chg

Financing Lease Liabilities, Non-Current Common Size

Deferred Lease Obligation, Non-Current

Deferred Lease Obligation, Non-Current %Chg

Deferred Lease Obligation, Non-Current Common Size

Lease Financing Obligation

Lease Financing Obligation %Chg

Lease Financing Obligation Common Size

Other Non-Current Liabilities

Other Non-Current Liabilities %Chg

Other Non-Current Liabilities Common Size

Total Liabilities

Total Liabilities %Chg

Total Liabilities Common Size

Redeemable Convertible Preferred Stock

Redeemable Convertible Preferred Stock %Chg

Redeemable Convertible Preferred Stock Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Additional Paid-in Capital

Additional Paid-in Capital %Chg

Additional Paid-in Capital Common Size

Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss) %Chg

Accumulated Other Comprehensive Income (Loss) Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Total Stockholders' Equity

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Other Receivables

Other Receivables %Chg

Other Receivables Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Inventories

Inventories %Chg

Inventories Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Long-Term Investments

Long-Term Investments %Chg

Long-Term Investments Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Accrued Expenses

Accrued Expenses %Chg

Accrued Expenses Common Size

Unearned Revenue

Unearned Revenue %Chg

Unearned Revenue Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	1,132	1,279	1,623	1,927	1,644	2,478
Cash and Cash Equivalents
Short-Term Investments	3,372	3,852	4,352	5,098	5,223	6,010
Investments
Total Cash and Cash Equivalents	4,504	5,131	5,975	7,025	6,867	8,488
Accounts Receivable	1,046	36	78	358	1,564	163
Accounts Receivable, Net
Other Receivables	—	—	—	—	—	—
Accounts Receivable from Related Party
Total Trade Receivables	1,046	36	78	358	1,564	163
Inventories	332	240	128	117	412	399
Inventory
Other Current Assets	716	764	585	599	823	611
Prepaid Expenses and Other Current Assets
Restricted Cash
Total Current Assets	6,598	6,171	6,766	8,099	9,666	9,661
Total Current Assets
Net Property, Plant & Equipment	2,864	2,919	2,964	2,955	3,165	2,971
Property, Plant and Equipment, Net
Right-of-Use Assets, Operating Leases
Long-Term Investments	2,143	2,374	2,418	2,494	2,335	2,326
Investments, Non-Current
Other Long-Term Assets	530	546	556	594	637	722
Restricted Cash, Non-Current
Deferred Tax Assets
Other Non-Current Assets
Total Assets	12,135	12,010	12,704	14,142	15,803	15,680
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	267	175	226	405	373	279
Accounts Payable
Accrued Expenses	1,178	987	1,001	1,427	1,376	1,333
Accrued Liabilities
Unearned Revenue	163	218	125	153	379	702
Deferred Revenue
Other Current Liabilities	73	192	252	221	73	49
Income Taxes Payable
Other Current Liabilities
Total Current Liabilities	1,681	1,572	1,604	2,206	2,201	2,363
Total Current Liabilities
Leases	686	698	702	710	1,304	1,244
Operating Lease Liabilities, Non-Current
Financing Lease Liabilities, Non-Current
Deferred Lease Obligation, Non-Current
Lease Financing Obligation
Other Long-Term Liabilities	438	341	332	325	371	361
Deferred Revenue, Non-Current
Other Non-Current Liabilities
Total Long-Term Liabilities	1,124	1,039	1,034	1,035	1,675	1,605
Total Liabilities	2,805	2,611	2,638	3,241	3,876	3,968
Total Liabilities

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Common Stock	—	—	—	—	—	—
Common Stock
Additional Paid-in Capital	1,254	1,127	982	866	751	631
Additional Paid-in Capital
Accumulated Other Comprehensive Income	27	23	10	-10	11	-71
Accumulated Other Comprehensive Income (Loss)
Retained Earnings	8,049	8,249	9,074	10,045	11,165	11,152
Retained Earnings
Total Common Shareholders' Equity	9,330	9,399	10,066	10,901	11,927	11,712
Total Stockholders' Equity
Minority Interests and Other	—	—	—	—	—	—
Redeemable Convertible Preferred Stock
Total Shareholders' Equity	9,330	9,399	10,066	10,901	11,927	11,712
Total Liabilities and Shareholders' Equity	12,135	12,010	12,704	14,142	15,803	15,680
Total Liabilities and Stockholders' Equity